| Autor: |
Lane, Emma L., Harrison, David J., Ramos‐Varas, Elena, Hills, Rachel, Turner, Sophie, Lelos, Mariah J. |
| Zdroj: |
Movement Disorders; Mar2022, Vol. 37 Issue 3, p613-619, 7p |
| Abstrakt: |
Background: The risk of graft‐induced dyskinesias (GIDs) presents a major challenge in progressing cell transplantation as a therapy for Parkinson's disease. Current theories implicate the presence of grafted serotonin neurons, hotspots of dopamine release, neuroinflammation and established levodopa‐induced dyskinesia. Objective: To elucidate the mechanisms of GIDs. Methods: Neonatally desensitized, dopamine denervated rats received intrastriatal grafts of human embryonic stem cells (hESCs) differentiated into either ventral midbrain dopaminergic progenitor (vmDA) (n = 15) or ventral forebrain cells (n = 14). Results: Of the eight rats with surviving grafts, two vmDA rats developed chronic spontaneous GIDs, which were observed at 30 weeks post‐transplantation. GIDs were inhibited by D2‐like receptor antagonists and not affected by 5‐HT1A/1B/5‐HT6 agonists/antagonists. Grafts in GID rats showed more microglial activation and lacked serotonin neurons. Conclusions: These findings argue against current thinking that rats do not develop spontaneous GID and that serotonin neurons are causative, rather indicating that GID can be induced in rats by hESC‐derived dopamine grafts and, critically, can occur independently of both previous levodopa exposure and grafted serotonin neurons. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text